Detailed Information

Cited 31 time in webofscience Cited 30 time in scopus
Metadata Downloads

Inhibition of nitric oxide generation by 23,24-dihydrocucurbitacin D in mouse peritoneal macrophages

Full metadata record
DC Field Value Language
dc.contributor.authorPark, Chang Seok-
dc.contributor.authorLim, Hyun-
dc.contributor.authorHan, Kee Jung-
dc.contributor.authorBaek, Sun Heum-
dc.contributor.authorSohn, Hyung Ok-
dc.contributor.authorLee, Dong Wook-
dc.contributor.authorKim, Yang-Gyun-
dc.contributor.authorYun, Hye-Young-
dc.contributor.authorBaek, Kwang Jin-
dc.contributor.authorKwon, Nyoun Soo-
dc.date.available2019-05-30T08:37:36Z-
dc.date.issued2004-05-
dc.identifier.issn0022-3565-
dc.identifier.issn1521-0103-
dc.identifier.urihttps://scholarworks.bwise.kr/cau/handle/2019.sw.cau/24846-
dc.description.abstractNitric oxide (NO) has various physiological functions. However, uncontrolled overproduction of NO can be toxic in many pathologic conditions involving inflammatory tissue damage. In the present study, we examined effects of 23,24-dihydrocucurbitacin D (DHCD) isolated from the root of Bryonia alba L. on macrophage NO generation. DHCD (< 80 μM) effectively abolished NO generation from macrophages activated with lipopolysaccharide and interferon-γ. DHCD decreased the levels of protein and mRNA for inducible NO synthase ( iNOS). DHCD potently blocked nuclear factor-κB (NF-κB) activation, a process necessary for transcriptional activation of iNOS. These results suggested that DHCD inhibited NO generation by blocking NF-κB activation and iNOS gene transcription. Because NF-κB activation is necessary not only for NO generation but also for many inflammatory processes, DHCD and its derivatives could be developed as anti-inflammatory drugs.-
dc.format.extent6-
dc.language영어-
dc.language.isoENG-
dc.publisherAMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS-
dc.titleInhibition of nitric oxide generation by 23,24-dihydrocucurbitacin D in mouse peritoneal macrophages-
dc.typeArticle-
dc.identifier.doi10.1124/jpet.103.063693-
dc.identifier.bibliographicCitationJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, v.309, no.2, pp 705 - 710-
dc.description.isOpenAccessN-
dc.identifier.wosid000220972900035-
dc.identifier.scopusid2-s2.0-11144353961-
dc.citation.endPage710-
dc.citation.number2-
dc.citation.startPage705-
dc.citation.titleJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS-
dc.citation.volume309-
dc.type.docTypeArticle-
dc.publisher.location미국-
dc.subject.keywordPlusFACTOR-KAPPA-B-
dc.subject.keywordPlusBARR-VIRUS ACTIVATION-
dc.subject.keywordPlusBRYONIA-ALBA L-
dc.subject.keywordPlusINTERFERON-GAMMA-
dc.subject.keywordPlusBACTERIAL LIPOPOLYSACCHARIDE-
dc.subject.keywordPlusCUCURBITANE TRITERPENOIDS-
dc.subject.keywordPlus2-STAGE CARCINOGENESIS-
dc.subject.keywordPlusANTITUMOR SUBSTANCES-
dc.subject.keywordPlusMURINE MACROPHAGES-
dc.subject.keywordPlusSYNTHASE GENE-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > College of Medicine > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Yun, Hye-Young photo

Yun, Hye-Young
의과대학 (의학부(기초))
Read more

Altmetrics

Total Views & Downloads

BROWSE